Citrate artificially masks the haemostatic effect of recombinant factor VIIa in dilutional coagulopathy

Annals of Hematology

Volumn 88, Issue 3, 2009, Pages 255-260

  Fenger Eriksen, Christian ^a   Ingerslev, Jürgen ^a   Tønnesen, Else ^a   Sørensen, Benny ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Corn trypsin inhibitor; Haemodilution; Plasma substitutes; Recombinant activated factor VII; Thrombelastography; Trisodium citrate

Indexed keywords

CITRIC ACID; HETASTARCH; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; TRYPSIN INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; DRUG EFFICACY; HEMODILUTION; HEMOSTASIS; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CITRIC ACID; FACTOR VIIA; HEMOSTASIS; HUMANS; MALE; RECOMBINANT PROTEINS;

EID: 59049090672     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0577-6     Document Type: Article

References (23)

1. Fenger-Eriksen C, Anker-Moller E, Heslop J, Ingerslev J, Sorensen B (2005) Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: Improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 94(3):324-329 Mar
2. Fries D, Krismer A, Klingler A et al (2005) Effect of fibrinogen on reversal of dilutional coagulopathy: A porcine model. Br J Anaesth 92(2):172-177
3. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL (1997) Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 42(4):716-720 Apr
4. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A et al (2007) Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 5(2):289-295 Feb
5. O'Connel N, Perry D, Hoerauf K (2005) Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 43:1711-1716
6. Eikelboom JW, Bird R, Blythe D, Coyle L, Gan E, Harvey M et al (2003) Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 14(8):713-717 Dec
7. Sørensen B, Johansen P, Christiansen K, Wöelke M, Ingerslev J (2003) Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 1(3):551-558 Mar
8. Sorensen B, Fenger-Eriksen C, Ingerslev J (2005) Recombinant factor VIIa fails to correct coagulopathy induced by haemodilution with colloid. Br J Anaesth 94(6):862-863 Jun
9. Engstrom M, Reinstrup P, Schott U (2005) An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxyethyl starch. BMC Blood Disorder 5:3-4
10. Baldassarre S, Vincent JL (1997) Coagulopathy induced by hydroxyethyl starch. Anesth Analg 84(2):451-453 Feb
11. Friederich P, Henny C, Messelink E (2003) Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled trial. Lancet 361:201-205
12. Mohr AM, Holcomb JB, Dutton RP, Duranteau J (2005) Recombinant activated factor VIIa and hemostasis in critical care: A focus on trauma. Crit Care 9(Suppl 5):S37-S42
13. Mann KG, Whelihan MF, Butenas S, Orfeo T (2007) Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost 5(10):2055-2061 Oct
14. Schneider DJ, Tracy PB, Mann KG, Sobel BE (1997) Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation 96(9):2877-2883 Nov 4
15. Butenas S, Brummel KE, Bouchard BA, Mann KG (2003) How factor VIIa works in hemophilia. J Thromb Haemost 1(6):1158-1160 Jun
16. Hoffman M, Monroe DM (2001) The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Semin Hematol 38(4 Suppl 12):6-9 Oct
17. Persson E (2000) Structure of human coagulation activated factor VII. Blood Coagul Fibrinolysis 11(Suppl 1):S15-S17 Apr
18. Rand MD, Lock JB, van't VC, Gaffney DP, Mann KG (1996) Blood clotting in minimally altered whole blood. Blood 88(9):3432-3445 Nov 1
19. Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95(4):858-865 Oct
20. Nielsen VG (2007) High-molecular-weight hydroxyethyl starch accelerates kallikrein-dependent clot initiation. J Trauma 62(6):1491-1494 Jun
21. Brummel-Ziedins K, Whelihan MF, Ziedins EG, Mann KG (2006) The resuscitative fluid you choose may potentiate bleeding. J Trauma 61(6):1350-1358 Dec
22. Breen P (2004) Basics of coagulation pathways. Int Anesthesiol Clin 42(3):1-9
23. Sorensen B, Persson E, Ingerslev J (2007) Factor VIIa analogue (V158D/ E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A. Br J Haematol 137(2):158-165 Apr